Please provide your email address to receive an email when new articles are posted on . The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical ...

Please provide your email address to receive an email when new articles are posted on . As presbyopia-correcting drops from different companies go through clinical trials and receive U.S. marketing ...

Because of the increasing prevalence and increased interest in reduced dependence on spectacles for reading, novel options continue to emerge. The traditional approach of blended vision with either ...

“We are excited to introduce Vivity because it addresses some common concerns of surgeons and cataract patients alike when considering presbyopia-correcting IOLs (PC-IOLs),” said Michael Onuscheck, ...

For many farsighted people, having different pairs of glasses for different viewing distances has been the norm. But with new technology, one pair of glasses could do the trick. Adaptive liquid ...

Clareon Vivity is the first and only non-diffractive extended depth of focus (EDOF) IOL with the wavefront-shaping X-WAVE Technology on Alcon’s most advanced lens platform1-6 Clareon Vivity joins ...

The FINANCIAL — Alcon, one of the global leaders in eye care and a division of Novartis, has received European CE Mark for its AcrySof IQ PanOptix trifocal intraocular lens (IOL) for patients ...

Alcon Inc. ALC recently announced the availability of Clareon Vivity — the first and only non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) on Alcon’s most advanced lens platform ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...